Skip to main content
. 2020 May 22;92(10):2050–2054. doi: 10.1002/jmv.25989

Figure 1.

Figure 1

SARS‐CoV‐2 IgG antibody showed enrichment in high levels in severe status and strong production in the early phase in female patients. A, Average concentration of SARS‐CoV‐2 IgG antibody in four status of COVID‐19 in male and female patients. B‐E, Comparison of SARS‐CoV‐2 IgG antibody concentration between male and female patients in mild (B), general (C), severe (D), and recovering status patients (E). F, percentage analysis of different concentration rage of IgG antibody in male (left) and female (right) patients in severe status. (G) Average concentration of the SARS‐CoV‐2 IgG antibody in indicate time points after disease onset. Patients were divided into four groups according to the time after disease onset. The IgG level was analyzed, respectively, in male and female patients. n (2‐3W, 3‐4W, 4‐5W, 5‐6W) = 8, 10, 49, 42 for male and 11, 15, 48, 76 for female. All data are expressed as mean ± SEM. IgG, immunoglobulin G; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; SEM, standard error of the mean